 |
InterPro: IPR000811 Glycosyl transferase, family 35
Protein matches
|
UniProtKB Matches: 1888 proteins |
|
Accession
|
IPR000811 Glyco_trans_35 |
Secondary
|
IPR011142
|
Type
|
Family |
Signatures
|
|
InterPro Relationships
|
|
Children
|
IPR011833 Glycogen/starch/alpha-glucan phosphorylase
IPR011834 Alpha-glucan phosphorylase
|
GO Term annotation
|
|
Process
|
GO:0005975 carbohydrate metabolic process
|
|
Function
|
GO:0004645 phosphorylase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
The biosynthesis of disaccharides, oligosaccharides and polysaccharides involves the action of hundreds of different glycosyltransferases. These enzymes catalyse the transfer of sugar moieties from activated donor molecules to specific acceptor molecules, forming glycosidic bonds. A classification of glycosyltransferases using nucleotide diphospho-sugar, nucleotide monophospho-sugar and sugar phosphates (EC:2.4.1.-) and related proteins into distinct sequence based families has been described [1]. This classification is available on the CAZy (CArbohydrate-Active EnZymes) web site [2]. The same three-dimensional fold is expected to occur within each of the families. Because 3-D structures are better conserved than sequences, several of the families defined on the basis of sequence similarities may have similar 3-D structures and therefore form 'clans'.
Glycosyltransferase family 35 GT35
comprises enzymes with only one known activity; glycogen and starch phosphorylase (EC:2.4.1.1).
The main role of glycogen phosphorylase (GPase) is to provide phosphorylated glucose molecules (G-1-P) [3]. GPase is a highly regulated allosteric enzyme. The net effect of the regulatory site allows the enzyme to operate at a variety of rates; the enzyme is not simply regulated as "on" or "off", but rather it can be thought of being set to operate at an ideal rate based on changing conditions at in the cell. The most important allosteric effector is the phosphate molecule covalently attached to Ser14.
This switches GPase from the b (inactive) state to the a (active) state. Upon phosphorylation, GPase attains about 80% of its Vmax. When the enzyme is not phosphorylated, GPase activity is practically non-existent at low AMP levels [4].
There is some apparent controversy as to the structure of GPase. All sources agree that the enzyme is multimeric, but there is apparent controversy as to the enzyme being a tetramer or a dimer. Apparently, GPase (in the a
form) forms tetramers in the crystal form. The consensus seems to be that `regardless of the a or b form, GPase functions as a dimer in vivo [5]. The GPase monomer is best described as consisting of two domains, an N-terminal domain and a C-terminal domain [6]. The C-terminal domain is often referred to as the catalytic domain. It consists of a beta-sheet core surrounded by layers of helical segments [5]. The vitamin cofactor pyridoxal phosphate (PLP) is covalently attached to the amino acid backbone. The N-terminal domain also consists of a central beta-sheet core and is surrounded by layers of helical segments. The N-terminal domain contains different allosteric effector sites to regulate the enzyme.
Bacterial phosphorylases follow the same catalytic mechanisms as their plant and animal counterparts, but differ considerably in terms of their substrate specificity and regulation. The catalytic domains are highly conserved while the regulatory sites are only poorly conserved. For maltodextrin phosphorylase from Escherichia coli the physiological role of the enzyme in the utilisation of maltidextrins is known in detail; that of all the other bacterial phosphorylases is still unclear. Roles in regulatuon of endogenous glycogen metabolism in periods of starvation, and sporulation, stress response or quick adaptation to changing environments are possible [7].
|
Structural links
|
|
Database links
|
Pfam Clan: CL0113.9
|
Publications
|
|
1.
|
Campbell JA, Davies GJ, Bulone V, Henrissat B.
A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities.
Biochem. J. 326 ( Pt 3) 929-39 1997
[PubMed: 9334165]
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=9334165
|
|
2.
|
Henrissat B, Coutinho PM.
Carbohydrate-Active Enzymes server.
1999
|
|
3.
|
Palm D, Klein HW, Schinzel R, Buehner M, Helmreich EJ.
The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis.
Biochemistry 29 1099-107 1990
[PubMed: 2182117]
http://dx.doi.org/10.1021/bi00457a001
|
|
4.
|
Zubay GL.
1998
|
|
5.
|
Newgard CB, Hwang PK, Fletterick RJ.
The family of glycogen phosphorylases: structure and function.
Crit. Rev. Biochem. Mol. Biol. 24 69-99 1989
[PubMed: 2667896]
http://intl.crbmb.com/cgi/content/abstract/24/1/69
|
|
6.
|
Buchbinder JL, Fletterick RJ.
Role of the active site gate of glycogen phosphorylase in allosteric inhibition and substrate binding.
J. Biol. Chem. 271 22305-9 1996
[PubMed: 8798388]
http://dx.doi.org/10.1074/jbc.271.37.22305
|
|
7.
|
Schinzel R, Nidetzky B.
Bacterial alpha-glucan phosphorylases.
FEMS Microbiol. Lett. 171 73-9 1999
[PubMed: 10077830]
|
Additional Reading
|
|
Onda K, Suzuki T, Shiraki R, Yonetoku Y, Negoro K, Momose K, Katayama N, Orita M, Yamaguchi T, Ohta M, Tsukamoto S.
Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
Bioorg. Med. Chem. 16 2008 5452-64
[PubMed: 18434170]
http://dx.doi.org/10.1016/j.bmc.2008.04.010
|
|
Wen X, Sun H, Liu J, Cheng K, Zhang P, Zhang L, Hao J, Zhang L, Ni P, Zographos SE, Leonidas DD, Alexacou KM, Gimisis T, Hayes JM, Oikonomakos NG.
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
J. Med. Chem. 51 2008 3540-54
[PubMed: 18517260]
http://dx.doi.org/10.1021/jm8000949
|
|
Alexacou KM, Hayes JM, Tiraidis C, Zographos SE, Leonidas DD, Chrysina ED, Archontis G, Oikonomakos NG, Paul JV, Varghese B, Loganathan D.
Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Proteins 71 2008 1307-23
[PubMed: 18041758]
http://dx.doi.org/10.1002/prot.21837
|
|
Campagnolo M, Campa C, Zorzi RD, Wuerges J, Geremia S.
X-ray studies on ternary complexes of maltodextrin phosphorylase.
Arch. Biochem. Biophys. 471 2008 11-9
[PubMed: 18164678]
http://dx.doi.org/10.1016/j.abb.2007.11.023
|
|
Leonidas DD, Oikonomakos NG, Papageorgiou AC, Acharya KR, Barford D, Johnson LN.
Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
Protein Sci. 1 1992 1112-22
[PubMed: 1304390]
http://www.proteinscience.org/cgi/content/abstract/1/9/1112
|
|
Anderka O, Loenze P, Klabunde T, Dreyer MK, Defossa E, Wendt KU, Schmoll D.
Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.
Biochemistry 47 2008 4683-91
[PubMed: 18373353]
http://dx.doi.org/10.1021/bi702397d
|
|
Fukui T, Shimomura S, Nakano K.
Potato and rabbit muscle phosphorylases: comparative studies on the structure, function and regulation of regulatory and nonregulatory enzymes.
Mol. Cell. Biochem. 42 1982 129-44
[PubMed: 7062910]
http://dx.doi.org/10.1007/BF00238507
|
|
|
InterPro 23.1
|